Simplified MIPS Reporting Using Quality Measures Created By and For Independent Rheumatologists

UREQA is United Rheumatology’s Qualified Clinical Data Registry, created to help independent rheumatologists optimize clinical quality and approved by CMS for 2021 MIPS reporting. UREQA introduces three new, rheumatology-specific quality measures based on United Rheumatology Clinical Practice Guidelines.

UREQA 2021 QCDR Measure Specifications

UREQA1 Ankylosing Spondylitis:
Controlled Disease

UREQA2 Ankylosing Spondylitis:
Appropriate Pharmacologic Therapy

UREQA4 Folic Acid Therapy for Patients Treated with Methotrexate